← Back to Search

Other

Non-Invasive Brain Stimulation for Stress Management

N/A
Recruiting
Research Sponsored by Baylor University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-30 years old
Be between 18 and 65 years old
Must not have
Current illness or infection (e.g., cold, flu)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following intervention (up to 60 minutes)
Awards & highlights

Summary

This trial will look at whether a non-invasive brain stimulation technique can help to lower stress levels.

Who is the study for?
This trial is for young adults aged 18-30 who are generally healthy. It's not suitable for those with chronic medical or neurological disorders, pregnant individuals, people currently ill (like having a cold or flu), or anyone unable to engage in physical exercise.Check my eligibility
What is being tested?
The study is testing the effects of transcranial infrared laser stimulation (LLLT) on how the body responds to stress at a cardiovascular and metabolic level. This non-invasive technique aims to modulate brain activity using light.See study design
What are the potential side effects?
Since LLLT is non-invasive and uses low-level lasers, side effects are typically minimal but may include slight discomfort at the site of application, headache, or dizziness immediately after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 30 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any current illness like a cold or flu.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately following intervention (up to 60 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately following intervention (up to 60 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Additional heart rate in response to acute psychological stress
Heart rate in response to acute psychological stress
Oxygen consumption in response to acute psychological stress
Secondary outcome measures
Perceived stress

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Transcranial infrared laser stimulationActive Control1 Intervention
Participants will receive transcranial infrared laser stimulation to the right forehead.
Group II: ShamPlacebo Group1 Intervention
Participants will receive sham laser to the right forehead.

Find a Location

Who is running the clinical trial?

Baylor UniversityLead Sponsor
59 Previous Clinical Trials
65,593 Total Patients Enrolled

Media Library

Low-level laser therapy (LLLT) (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05298956 — N/A
Stress Reaction Research Study Groups: Sham, Transcranial infrared laser stimulation
Stress Reaction Clinical Trial 2023: Low-level laser therapy (LLLT) Highlights & Side Effects. Trial Name: NCT05298956 — N/A
Low-level laser therapy (LLLT) (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05298956 — N/A
~0 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top